{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:46:19Z","timestamp":1788918379403,"version":"build-2803163510"},"reference-count":33,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.3201\/eid1802.111126","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T19:02:42Z","timestamp":1374001362000},"page":"226-233","source":"Crossref","is-referenced-by-count":52,"title":["Declining Guillain-Barr\u00e9 Syndrome after Campylobacteriosis Control, New Zealand, 1988\u20132010"],"prefix":"10.3201","volume":"18","author":[{"given":"Michael G.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Kvalsvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Sears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid1802.111126-201307161502-R1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome.","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"key-10.3201\/eid1802.111126-201307161502-R2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barr\u00e9 syndrome worldwide.","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"key":"key-10.3201\/eid1802.111126-201307161502-R3","doi-asserted-by":"crossref","unstructured":"Jacobs BC, van Belkum A, Endtz HP. Guillain-Barr\u00e9 syndrome andCampylobacterinfection. In: Nachamkin I, Szymanski CM, Blaser MJ, editors.Campylobacter, 3rd ed. Washington: ASM Press; 2008. p. 245\u201362.","DOI":"10.1128\/9781555815554.ch13"},{"key":"key-10.3201\/eid1802.111126-201307161502-R4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/CMR.11.3.555","article-title":"Campylobacter species and Guillain-Barr\u00e9 syndrome.","volume":"11","author":"Nachamkin","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid1802.111126-201307161502-R5","first-page":"U2264","article-title":"Regulation of chicken contamination is urgently needed to control New Zealand's serious campylobacteriosis epidemic.","volume":"119","author":"Baker","year":"2006","journal-title":"N Z Med J"},{"key":"key-10.3201\/eid1802.111126-201307161502-R6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1017\/S0950268806006583","article-title":"Is the major increase in notified campylobacteriosis in New Zealand real?","volume":"135","author":"Baker","year":"2007","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid1802.111126-201307161502-R7","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3201\/eid1706.101272","article-title":"Marked campylobacteriosis decline after interventions aimed at poultry, New Zealand.","volume":"17","author":"Sears","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1802.111126-201307161502-R8","first-page":"135","article-title":"Keep the focus on contaminated poultry to further curtail New Zealand\u2019s campylobacteriosis epidemic.","volume":"124","author":"Baker","year":"2011","journal-title":"N Z Med J"},{"key":"key-10.3201\/eid1802.111126-201307161502-R9","unstructured":"Institute of Environmental Science and Research Ltd. Notifiable and other diseases in New Zealand: annual report 2010. Porirua (New Zealand): The Institute; 2011."},{"key":"key-10.3201\/eid1802.111126-201307161502-R10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/aje\/153.6.610","article-title":"Incidence of Guillain-Barr\u00e9 syndrome following infection with Campylobacter jejuni.","volume":"153","author":"McCarthy","year":"2001","journal-title":"Am J Epidemiol"},{"key":"key-10.3201\/eid1802.111126-201307161502-R11","unstructured":"Rothman K, Greenland S, Lash T, eds. Modern epidemiology, 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008."},{"key":"key-10.3201\/eid1802.111126-201307161502-R12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3329\/jhpn.v28i6.6602","article-title":"Quantifying the association between Campylobacter infection and Guillain-Barr\u00e9 syndrome: a systematic review.","volume":"28","author":"Poropatich","year":"2010","journal-title":"J Health Popul Nutr"},{"key":"key-10.3201\/eid1802.111126-201307161502-R13","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.","volume":"374","author":"Black","year":"2009","journal-title":"Lancet"},{"key":"key-10.3201\/eid1802.111126-201307161502-R14","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(09)61917-6","article-title":"H1N1 vaccine safety monitoring: beyond background rates.","volume":"375","author":"DeStefano","year":"2010","journal-title":"Lancet"},{"key":"key-10.3201\/eid1802.111126-201307161502-R15","first-page":"U893","article-title":"Lack of association between long-term illness and infectious intestinal disease in New Zealand.","volume":"117","author":"Lake","year":"2004","journal-title":"N Z Med J"},{"key":"key-10.3201\/eid1802.111126-201307161502-R16","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1212\/01.wnl.0000310983.38724.d4","article-title":"Guillain-Barr\u00e9 syndrome.","volume":"70","author":"Alshekhlee","year":"2008","journal-title":"Neurology"},{"key":"key-10.3201\/eid1802.111126-201307161502-R17","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1371\/journal.pone.0000344","article-title":"Guillain-Barr\u00e9 syndrome and preceding infection with Campylobacter, influenza and Epstein-Barr virus in the general practice research database.","volume":"2","author":"Tam","year":"2007","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid1802.111126-201307161502-R18","doi-asserted-by":"crossref","first-page":"145S","DOI":"10.1046\/j.1365-2672.2001.01363.x","article-title":"Guillain-Barr\u00e9 syndrome and Campylobacter jejuni infection.","volume":"30","author":"Hadden","year":"2001","journal-title":"Symp Ser Soc Appl Microbiol"},{"key":"key-10.3201\/eid1802.111126-201307161502-R19","article-title":"Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice.","author":"Tam","year":"2011","journal-title":"Gut"},{"key":"key-10.3201\/eid1802.111126-201307161502-R20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3201\/eid1410.071042","article-title":"Estimating community incidence of Salmonella, Campylobacter, and Shiga toxin\u2013producing Escherichia coli infections, Australia.","volume":"14","author":"Hall","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1802.111126-201307161502-R21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis.","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"key-10.3201\/eid1802.111126-201307161502-R22","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/01.WNL.0000055091.96905.D0","article-title":"Guillain-Barr\u00e9 syndrome: a prospective, population-based incidence and outcome survey.","volume":"60","author":"Chi\u00f2","year":"2003","journal-title":"Neurology"},{"key":"key-10.3201\/eid1802.111126-201307161502-R23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1468-1331.2000.00006.x","article-title":"Incidence of Guillain-Barr\u00e9 syndrome in Sweden 1996.","volume":"7","author":"Cheng","year":"2000","journal-title":"Eur J Neurol"},{"key":"key-10.3201\/eid1802.111126-201307161502-R24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain-Barr\u00e9 syndrome.","volume":"56","author":"Hadden","year":"2001","journal-title":"Neurology"},{"key":"key-10.3201\/eid1802.111126-201307161502-R25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.54.3.620","article-title":"Mild forms of Guillain-Barr\u00e9 syndrome in an epidemiologic survey in the Netherlands.","volume":"54","author":"Van Koningsveld","year":"2000","journal-title":"Neurology"},{"key":"key-10.3201\/eid1802.111126-201307161502-R26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S1473-3099(10)70140-7","article-title":"Guillain-Barr\u00e9 syndrome after exposure to influenza virus.","volume":"10","author":"Lehmann","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid1802.111126-201307161502-R27","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1016\/j.leukres.2010.02.036","article-title":"Guillain-Barr\u00e9 syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: a case report and review of the literature.","volume":"34","author":"Abbi","year":"2010","journal-title":"Leuk Res"},{"key":"key-10.3201\/eid1802.111126-201307161502-R28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/mus.20163","article-title":"Lymphoma and peripheral neuropathy: a clinical review.","volume":"31","author":"Kelly","year":"2005","journal-title":"Muscle Nerve"},{"key":"key-10.3201\/eid1802.111126-201307161502-R29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/10428190701760003","article-title":"Guillain-Barr\u00e9 syndrome after transplantation.","volume":"49","author":"Zhang","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key-10.3201\/eid1802.111126-201307161502-R30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/1471-2458-10-332","article-title":"A surveillance sector review applied to infectious diseases at a country level.","volume":"10","author":"Baker","year":"2010","journal-title":"BMC Public Health"},{"key":"key-10.3201\/eid1802.111126-201307161502-R31","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review.","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"key-10.3201\/eid1802.111126-201307161502-R32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(02)00158-2","article-title":"Long-term impact on work and private life after Guillain-Barr\u00e9 syndrome.","volume":"201","author":"Bernsen","year":"2002","journal-title":"J Neurol Sci"},{"key":"key-10.3201\/eid1802.111126-201307161502-R33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1539-6924.2009.01269.x","article-title":"Risk ranking for foodborne microbial hazards in New Zealand: burden of disease estimates.","volume":"30","author":"Lake","year":"2010","journal-title":"Risk Anal"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/18\/2\/11-1126_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:12:34Z","timestamp":1733285554000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/18\/2\/11-1126_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1802.111126","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}